SEPTRALU study. Spanish Series of Patients Treated with Lutetium177
INDEPENDENT POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: SPANISH SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Execution start: 12/07/2021
- End of execution: 30/07/2031
- IP: MARIA ANGUSTIAS WALLS OF SOURCES